ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Trinity Biotech (TRIB) Technical (Analysis) Reports Trinity Biotech ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Trinity Biotech (TRIB)

Technical Analysis Report for USA stock TRIB Trinity Biotech. Dated: 06 Feb 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology In Vitro In Vivo Diagnostic Substances in USA stock exchange

If you are looking for Tomorrow's Movement Predictions for USA stock TRIB Trinity Biotech then click here. or read Experts views on Trinity Biotech or Forecast & share price targets of Trinity Biotech

Trinity Biotech Opened at 0.71 and Closed at: 0.80, which is 11.25% of previous session's close. It moved within a range of 0.70 and 0.80
The session was a Bullish session with an average volume of 155200, which is -10.82% of previous session's volumes.

    A Golden cross was found 8 days back on short term averages

    Support for tomorrow is 0.75 and resistance for tomorrow is 0.85
    These support and resistance points are valid for the first 5-15 minutes charts

    Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

    Support for tomorrow's hourly charts is 0.73, 0.67 resistance for tomorrow's hourly charts is 0.83, 0.87

    10 Day SMA for Trinity Biotech (TRIB) is 0.83 and stock is trading below these levels. This is not a good sign for its short term trend

    20 Day SMA for Trinity Biotech (TRIB) is 0.78 and the stock is trading above these levels. This is a good sign for its mid term trend

    50 Day SMA for Trinity Biotech (TRIB) is 0.88 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

    100 Day SMA is 0.95 and the stock is trading below these levels. This is not a good sign for its long term trend

    200 Day SMA Trinity Biotech is 0.92 and stock is trading below these levels. This is not a good sign for its long term trend

    20 DMA of Trinity Biotech is at 0.78 and 200 DMA is at 0.92, while 50 DMA and 100 DMA are at 0.88 and 0.95 respectively

    Trinity Biotech (TRIB) moving average of 20 SMA is at 0.78 and 20 EMA is at 0.82

    Trinity Biotech (TRIB) moving average of 50 SMA is at 0.88 and 50 EMA is at 0.84

    Trinity Biotech (TRIB) moving average of 100 SMA is at 0.95 and 100 EMA is at 0.95

    Trinity Biotech (TRIB) moving average of 200 SMA is at 0.92 and 200 EMA is at 1.14

    Takeda Pharmaceutical has performed better than Trinity Biotech in short term. You could have earned much better returns by investing in Takeda Pharmaceutical, about 0.1% more returns!

    Trinity Biotech has performed better than Iqvia Holdings in short term. Holding Trinity Biotech could be a better choice for now!

    Trinity Biotech has performed better than Edwards Lifesciences in short term. Holding Trinity Biotech could be a better choice for now!

    Trinity Biotech has performed better than Becton Dickinson in short term. Holding Trinity Biotech could be a better choice for now!

    Trinity Biotech has performed better than Xbiotech Inc in short term. Holding Trinity Biotech could be a better choice for now!

    Trinity Biotech has performed better than Bio Techne in short term. Holding Trinity Biotech could be a better choice for now!

    Trinity Biotech has performed better than Strata Skin in short term. Holding Trinity Biotech could be a better choice for now!

    Scholar Rock has performed better than Trinity Biotech in short term. You could have earned much better returns by investing in Scholar Rock, about 3.31% more returns!

    Trinity Biotech has performed better than Sarepta Therapeutics in short term. Holding Trinity Biotech could be a better choice for now!

    Trinity Biotech has performed better than Organogenesis Holdings in short term. Holding Trinity Biotech could be a better choice for now!

    Trinity Biotech has performed better than Myriad Genetics in short term. Holding Trinity Biotech could be a better choice for now!

    Trinity Biotech has performed better than Lantheus Holdings in short term. Holding Trinity Biotech could be a better choice for now!

    Trinity Biotech has performed better than Kamada in short term. Holding Trinity Biotech could be a better choice for now!

    Trinity Biotech has performed better than Ionis Pharmaceuticals in short term. Holding Trinity Biotech could be a better choice for now!

    Trinity Biotech has performed better than Inovio Pharmaceuticals in short term. Holding Trinity Biotech could be a better choice for now!

    Trinity Biotech has performed better than Immuron in short term. Holding Trinity Biotech could be a better choice for now!

    Trinity Biotech has performed better than Cellectis S in short term. Holding Trinity Biotech could be a better choice for now!

    Trinity Biotech has performed better than Axogen Inc in short term. Holding Trinity Biotech could be a better choice for now!

    Trinity Biotech has performed better than Anixa Biosciences in short term. Holding Trinity Biotech could be a better choice for now!

    Trinity Biotech Technical analysis of indicators

    Price action analysis of Trinity Biotech (TRIB) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small

    ADX buy sell signal for Trinity Biotech stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

    MACD generated a SELL signal for Trinity Biotech in short term and the sell signal is strong.

    Trinity Biotech Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!

    Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up

    CCI has generated a buy signal for Trinity Biotech in short term but BUY signal is weak.

    RSI is generating a BUY signal in short term and the buying is gaining momentum.

    MRSI is in positive zone. This is a BUY zone

    Although the stock is in the BUY zone, but buying might be slowing down

    Stock of Trinity Biotech is picking up selling momentum according to indicator.

    Volume based indicators are showing selling momentum.

    Volume Weighted Averaged Price (VWAP) for short term is 0.87 and Trinity Biotech TRIB stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

    People seem to be coming out and selling the Trinity Biotech TRIB stock. Volume based technical analysis of Trinity Biotech TRIB stock is negative.

    Trinity Biotech Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

    Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

    Tomorrow's Predictions

    You should also read Tomorrow's Movement Predictions for USA stock TRIB Trinity Biotech These predictions are based on various factors, are easy to understand, and upto 75% accurate!

    And TRIB Experts View which covers a lot of information including buying and selling signals

    TRIB future forecast & share price targets

    You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Trinity Biotech or View Candle Stick Charts here

    Chart Trinity Biotech (TRIB)  Technical (Analysis) Reports Trinity Biotech [

    Videos related to: Trinity Biotech (TRIB) Technical (Analysis) Reports Trinity Biotech ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

    Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts

    Hindi Video Most Important Stock Market Video. No Success Without This Formula

    Trinity Biotech (TRIB)  Technical (Analysis) Reports Trinity Biotech [

     

    Back to top